Ever thought of extending your training, being a part of ground-breaking research, changing health policy in developing nations? What about expanding your network, or becoming part of a passionate global team of researchers and change-makers?

We could help make your dream come true through the MIGA Doctors in Training Grants Program, just as we assisted Dr Henry Zhao, Dr Annabelle Enriquez and Dr Simone Sandler:

Dr Henry Zhao 
Doctor of Philosophy in Clinical Acute Stroke Medicine 

Though the Melbourne Mobile Stroke Unit is an important clinical asset, it also allows us to perform ground-breaking research. I am coordinating the world’s first clinical trial of a drug designed to try to halt bleeding (using Tranexamic acid) for patients with a bleeding stroke in a Mobile Stroke Unit. There are otherwise no other treatments available for this devastating condition.

This trial would not be feasible in hospital, as patients must be treated within the first few hours of stroke onset, something only the Mobile Stroke Unit can usually achieve. We also have a second important clinical trial of a newer clot dissolving drug (Tenecteplase), which has shown that it has superior effect than the usual drug that is used. This, along with earlier treatment in the community, is hoped to be able to save more brain tissue and improve outcomes for patients.

Dr Annabelle Enriquez 
Master of Medicine, Sydney 

At the start of the millennium, it took 23 laboratories 13 years and $3 billion to sequence the entire human genome. There are now powerful sequencing machines that can sequence up to 18,000 entire human genomes annually.  The goal of my research is to identify the causes of congenital anomalies, specifically the genetic changes that lead to cardiac and vertebral malformation.  Congenital anomalies affect more children than most chronic childhood diseases including autism, cancer and type 1 diabetes.

Many families endure a diagnostic odyssey as they try to find the reason why their child is, or children, are affected. A definitive molecular diagnosis is important for overall patient management, even when it does not necessarily change treatmentand exonerates the parents, as they usually feel guilt for somehow causing the Congenital Malformation.  It also provides relief from the uncertainty, allowing families to move on, plan for the future and possibly explore therapeutic options.

Dr Simone Sandler 
Harvard Program in Global Surgery and Social Change 

The greatest resource I have been able to access during my time in the Program in Global Surgery and Social Change (PGSSC) has been the extraordinary professional networks and mentors I have met from around the world.  Some of these amazing people include Massachusetts Eye and Ear hospital global otolaryngologists, who are facilitating outreach and education clinics in nearby developing nations such as Haiti, passionate general surgeons in rural India who are pioneering equitable healthcare for disenfranchised local tribal populations, and colleagues at the PGSSC who are facilitating surgical policy change with ministries of health in a variety of developing countries such as Zambia and Tanzania.

Working amongst PGSSC colleagues has been a warm and hospitable experience – a work environment both supportive and uplifting. I am grateful for the wonderful opportunity to rub shoulders and pick the brains of some of the most inspiring ‘change-makers’ in the field of global surgery.


Expand your mind, expand your experience and be the change you want to see!

Visit www.miga.com.au/home/grants-programs/dit-grants-program to apply and view the full reports from our amazing grant recipients.

2018 Applications close Friday, 2 November 2018. 

Perhaps we can help make your dream a reality!

Other resources

  1. Fulfil your destiny

    Find out more about our DIT Grants Program

Prefer to read a PDF of the Bulletin? Download it here

We'd love to hear your feedback, comments and ideas

SUBMIT FEEDBACK